Skip to main content
SpringerLink
Log in

Indium-111-octreotide Scintigraphy, Intraoperative Gamma-detector Localisation and Somatostatin Receptor Expression in Primary Human Breast Cancer

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

12 women with primary breast cancer underwent somatostatin receptor scintigraphy (SRS) with 111In-DTPA-D-Phe1-octreotide. The tumour sizes varied between 2 and 5 cm and were all, except one, palpable at clinical examination. Tumour biopsies were taken with additional sampling from normal breast tissue, fat, muscle, axillary lymph nodes and peripheral blood. Ratios between the 111In activity concentration in the tissue biopsies (Ti) and in peripheral blood (B) as well as in normal breast tissue (Br) were calculated. In 8/12 patients the scintillation detector was used intraoperatively for radioactivity measurements of the biopsies in situ and ex vivo. The sstr-subtype profiles were determined by northern blot analysis and the relative expression of sstr2 by ribonuclease protection assay (RPA) and immunocytochemistry. Preoperative SRS visualised all primary breast cancer tumours. The scintigraphic image showed no correlation with the histopathological type of the tumour or with the abundance of oestrogen/progesterone receptors on the tumour. Two patients with a massive tumour infiltration of the lymph nodes had a distinct positive SRS of the ipsilateral axilla. In one patient with three nodal metastases the scintigraphic image of the axilla was weak but visible. Four other patients with a negative axillary scintigraphy had 1–2 lymph node metastases. The Ti/B ratios for the breast tumours varied between four and 33 and were not different from Ti/Br ratios. In lymph node metastases the Ti/B ratios were higher (10–41). Intraoperative detector measurements showed a significant difference between the breast tumour and normal tissue in 2/8 patients in situ. Similar measurements on excised tissues (ex vivo) showed a significant difference in 6/8 patients. Two patients with lymph node metastases exhibited a significantly increased uptake ex vivo by detector measurements, but in only one of them in situ. All tumour biopsies expressed the presence of sstr1, 3, 4 and 5, but not of sstr2 at northern analysis. On the other hand, sstr2 was detected in all tumours by RPA and immunocytochemistry. Preoperative SRS visualised primary breast cancer lesions in all 12 patients. SRS could also demonstrate extensive axillary tumour infiltration. Intraoperative use of the scintillation detector could not exclude axillary metastases in situ. The low Ti/B values of both primary tumours and metastases indicate limitations of the radiopharmaceutical used.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ain KB, Taylor KD: Somatostatin analogs affect prolifera-tion of human thyroid carcinoma cell lines in vitro. J Clin Endocrinol Metab 78(5): 1097–1102, 1994

    PubMed  Google Scholar 

  2. Weckbecker G, Liu R, Tolcsvai L, Bruns C: Antiproliferative effects of the somatostatin analogue octreotide (SMS 201–99575-1 human breast cancer cells in vivo and in vitro. Cancer Res 52(18): 4973-4978, 1992

    PubMed  Google Scholar 

  3. Weckbecker G, Raulf F, Bodmer D, Bruns C: Indirect antipro-liferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice. Yale J Biol Med 70(5–6): 549-554, 1997

    PubMed  Google Scholar 

  4. Yamada Y, Post SR, Wang K, Tager HS, Bell GI, Seino S: Cloning and functional characterization of a family of hu-man and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc Natl Acad Sci USA 89(1): 251–255, 1992

    PubMed  Google Scholar 

  5. Yamada Y, Reisine T, Law SF, Ihara Y, Kubota A, Kagimoto S, Seino M, Seino Y, Bell GI, Seino S: Somatostatin receptors, an expanding gene family: cloning and functional characteriz-ation of human SSTR3, a protein coupled to adenylyl cyclase. Mol Endocrinol 6(12): 2136–2142, 1992.

    PubMed  Google Scholar 

  6. Rohrer L, Raulf F, Bruns C, Buettner R, Hofstaedter F, Schule R: Cloning and characterization of a fourth human soma-tostatin receptor. Proc Natl Acad Sci USA 90(9): 4196–4200, 1993

    PubMed  Google Scholar 

  7. Yamada Y, Kagimoto S, Kubota A, Yasuda K, Masuda K, Someya Y, Ihara Y, Li Q, Imura H, Seino S: Cloning, func-tional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype. Biochem Biophys Res Commun 195(2): 844–852, 1993

    PubMed  Google Scholar 

  8. Bruns C, Weckbecker G, Raulf F, Kaupmann K, Schoeffter P, Hoyer D, Lubbert H: Molecular pharmacology of somatostatin-receptor subtypes. Ann NY Acad Sci 733: 138–146, 1994

    PubMed  Google Scholar 

  9. Pollak MN, Polychronakos C, Guyda H: Somatostatin ana-logue SMS 201–995 reduces serum IGF-I levels in patients with neoplasms potentially dependent on IGF-I. Anticancer Res 9(4): 889-891, 1989

    PubMed  Google Scholar 

  10. Woltering EA, Watson JC, Alperin-Lea RC, Sharma C, Keenan E, Kurozawa D, Barrie R: Somatostatin analogs: an-giogenesis inhibitors with novel mechanisms of action. Invest New Drugs 15(1): 77–86, 1997

    PubMed  Google Scholar 

  11. Ahlman H, Tisell LE, Wangberg B, Nilsson O, Forssell-Aronsson E, Fjalling M: Somatostatin receptor imaging in patients with neuroendocrine tumors: preoperative and post-operative scintigraphy and intraoperative use of a scintillation detector. Semin Oncol 21(5 suppl 13): 21–28, 1994

    Google Scholar 

  12. Ahlman H, Wangberg B, Tisell LE, Nilsson O, Fjalling M, Forssell-Aronsson E: Clinical efficacy of octreotide scinti-graphy in patients with midgut carcinoid tumours and evalu-ation of intraoperative scintillation detection. Br J Surg 81(8): 1144–1149, 1994

    PubMed  Google Scholar 

  13. Baudin E, Lumbroso J, Schlumberger M, Leclere J, Giammarile F, Gardet P, Roche A, Travagli JP, Parmentier C: Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma. J Nucl Med 37(6): 912–916, 1996

    PubMed  Google Scholar 

  14. Tisell LE, Ahlman H, Wangberg B, Hansson G, Molne J, Nilsson O, Lindstedt G, Fjalling M, Forssell-Aronsson E: Somatostatin receptor scintigraphy in medullary thyroid car-cinoma. Br J Surg 84(4): 543–547, 1997

    PubMed  Google Scholar 

  15. Kölby L, Wängberg B, Ahlman H, Tisell LE, Fjälling M, Forssell-Aronsson E, Nilsson O: Somatostatin receptor subtypes, octreotide scintigraphy, and clinical response to octreotide treatment in patients with neuroendocrine tumors. World J Surg 22(7): 679–683, 1998

    PubMed  Google Scholar 

  16. Wängberg B, Forssell-Aronsson E, Tisell LE, Nilsson O, Fjälling M, Ahlman H: Intraoperative detection of somatostatin-receptor-positive neuroendocrine tumours using indium-111-labelled DTPA-D-Phe1-octreotide. Br J Cancer 73(6): 770–775, 1996

    PubMed  Google Scholar 

  17. Adams S, Baum RP, Hertel A, Wenisch HJ, Staib-Sebler E, Herrmann G, Encke A, Hor G: Intraoperative gamma probe detection of neuroendocrine tumors. J Nucl Med 39(7): 1155–1160, 1998

    PubMed  Google Scholar 

  18. Fjälling M, Andersson P, Forssell-Aronsson E, Gretarsdottir J, Johansson V, Tisell LE, Wängberg B, Nilsson O, Berg G, Michanek A: Systemic radionuclide therapy using indium-111-DTPA-D-Phe1-octreotide in midgut carcinoid syndrome. J Nucl Med 37(9): 1519–1521, 1996

    PubMed  Google Scholar 

  19. Setyono-Han B, Henkelman MS, Foekens JA, Klijn GM: Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells. Cancer Res 47(6): 1566–1570, 1987

    PubMed  Google Scholar 

  20. Sharma K, Srikant CB: Induction of wild-type p53, Bax, and acidic endonuclease during somatostatin-signaled apoptosis in MCF-7 human breast cancer cells. Int J Cancer 76(2): 259–266, 1998

    PubMed  Google Scholar 

  21. Bontenbal M, Foekens JA, Lamberts SW, de Jong FH, van Putten WL, Braun HJ, Burghouts JT, van der Linden GH, Klijn JG: Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast can-cer: a randomized study with long-term follow-up. Br J Cancer 77(1): 115–122, 1998

    PubMed  Google Scholar 

  22. van Eijck CH, Krenning EP, Bootsma A, Oei HY, van Pel R, Lindemans J, Jeekel J, Reubi JC, Lamberts SW: Somatostatin-receptor scintigraphy in primary breast cancer [see com-ments]. Lancet 343(8898): 640–643, 1994

    Article  PubMed  Google Scholar 

  23. Chomczynski P, Sacchi N: Single-step method of RNA isol-ation by acid guanidinium thiocyanate-phenol-chloroform ex-traction. AnalBiochem 162(1): 156–159, 1987

    Google Scholar 

  24. Forssell-Aronsson E, Nilsson O, Benjegård SA, Bernhardt P: 111 In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors. J Nucl Med 41(4): 636–642, 2000

    PubMed  Google Scholar 

  25. Nilsson O, Kölby L, Wängberg B, Wigander A, Billig H, William-Olsson L, Fjälling M, Forssell-Aronsson E, Ahlman H: Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours. Br J Cancer 77(4): 632–637, 1998

    PubMed  Google Scholar 

  26. Reubi JC, Waser B, Foekens JA, Klijn JG, Lamberts SW, Laissue J: Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: relationship to EGF receptors. Int J Cancer 46(3): 416–420, 1990

    PubMed  Google Scholar 

  27. Prevost G, Hosford D, Thomas F: Receptors for somatostatin and somatostatin analogues in human breast tumors. Ann N Y Acad Sci 733: 147–154, 1994

    PubMed  Google Scholar 

  28. Bajc M, Ingvar C, Palmer J: Dynamic indium-111-pentetreo-tide scintigraphy in breast cancer. J Nucl Med 37(4): 622–626, 1996

    PubMed  Google Scholar 

  29. Reubi JC, Schaer JC, Waser B, Mengod G: Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization. Cancer Res 54(13): 3455–3459, 1994

    PubMed  Google Scholar 

  30. Reubi JC, Schaer JC, Laissue JA, Waser B: Somatostatin re-ceptors and their subtypes in human tumors and in peritumoral vessels. Metabolism 45 (8 suppl 1): 39–41, 1996

    PubMed  Google Scholar 

  31. John M, Meyerhof W, Richter D, Waser B, Schaer JC, Scherubl H, Boese-Landgraf J, Neuhaus P, Ziske C, Molling K: Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2. Gut 38(1): 33–39, 1996

    PubMed  Google Scholar 

  32. Vikic-Topic S, Raisch KP, Kvols LK, Vuk-Pavlovic S: Expres-sion of somatostatin receptor subtypes in breast carcinoma, carcinoid tumor, and renal cell carcinoma. J Clin Endocrinol Metab 80(10): 2974–2979, 1995

    PubMed  Google Scholar 

  33. Evans AA, Crook T, Laws SA, Gough AC, Royle GT, Primrose JN: Analysis of somatostatin receptor subtype mRNA expression in human breast cancer. Br J Cancer 75(6): 798–803, 1997

    PubMed  Google Scholar 

  34. Ain KB, Taylor KD, Tofiq S, Venkataraman G: Somatostatin receptor subtype expression in human thyroid and thyroid car-cinoma cell lines. J Clin Endocrinol Metab 82(6): 1857–1862, 1997

    PubMed  Google Scholar 

  35. Forssell-Aronsson E, Fjalling M, Nilsson O, Tisell LE, Wangberg B, Ahlman H: Indium-111 activity concentra-.Somatostatin receptors and breast cancer 111 tion in tissue samples after intravenous injection of indium-111-DTPA-D-Phe-1-octreotide. J Nucl Med 36(1): 7–12, 1995

    PubMed  Google Scholar 

  36. Xu Y, Song J, Berelowitz M, Bruno JF: Estrogen regulates so-matostatin receptor subtype 2 messenger ribonucleic acid ex-pression in human breast cancer cells. Endocrinology 137(12): 5634–5640, 1996

    PubMed  Google Scholar 

  37. Mansi L, Rambaldi PF, Procaccini E, Gregoio FD, Laprovit-era A, Pecori B, Vecchio WD: Scintimammography with technetium-99m tetrofosmin in the diagnosis of breast cancer and lymph node metastases. Eur J Nucl Med 23(8): 932–939, 1996

    PubMed  Google Scholar 

  38. Vural G, Unlu M, Atasever T, Ozur I, Ozdemir A, Gokcora N: Comparison of indium-111 octreotide and thallium-201 scintigraphy in patients mammographically suspected of hav-ing breast cancer: preliminary results. Eur J Nucl Med 24(3): 312–315, 1997

    PubMed  Google Scholar 

  39. Chiti A, Agresti R, Maffioli LS, Tomasic G, Savelli G, Crippa F, Pilotti S, Greco M, Bombardieri E: Breast cancer staging using technetium-99m sestamibi and indium-111 pentet-reotide single-photon emission tomography. Eur J Nucl Med 24(2): 192–196, 1997

    PubMed  Google Scholar 

  40. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, Costa A, de Cicco C, Geraghty JG, Luini A: Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes [see comments]. Lancet 349(9069): 1864–1867, 1997

    PubMed  Google Scholar 

  41. Zurrida S, Galimberti V, Orvieto E, Robertson C, Ballardini B, Cremonesi M, De Cicco C, Luini A: Radioguided sentinel node biopsy to avoid axillary dissection in breast cancer. Ann Surg Oncol 7(1): 28–31, 2000

    PubMed  Google Scholar 

  42. Ahlman H, Tisell LE, Wangberg B, Nilsson O, Fjalling M, Forssell-Aronsson E: Somatostatin receptors on neuroendo-crine tumors-a way to intraoperative diagnosis and localiza-tion. Yale J Biol Med 67(3–4): 215-221, 1994

    PubMed  Google Scholar 

  43. Pollak M: Enhancement of the anti-neoplastic effects of tamoxifen by somatostatin analogues. Digestion 57(suppl 1): 29–33, 1996

    PubMed  Google Scholar 

  44. Slooter GD, Breeman WA, Marquet RL, Krenning EP, van Eijck CH: Anti-proliferative effect of radiolabelled octreotide in a metastases model in rat liver. Int J Cancer 81(5): 767–771, 1999

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Surgery, Sahlgrenska University Hospital, Göteborg, Sweden

    Jan Skånberg, Håkan Ahlman & Svante Jansson

  2. Departments of Radiation Physics, Sahlgrenska University Hospital, Göteborg, Sweden

    Sven-Anders Benjegård & Eva B. Forssell-Aronsson

  3. Departments of Nuclear Medicine, Sahlgrenska University Hospital, Göteborg, Sweden

    Martha Fjälling & Madis Suurkula

  4. Departments of Pathology, Sahlgrenska University Hospital, Göteborg, Sweden

    Sayed Hossein Hashemi & Ola Nilsson

Authors
  1. Jan Skånberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Håkan Ahlman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sven-Anders Benjegård
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Martha Fjälling
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Eva B. Forssell-Aronsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sayed Hossein Hashemi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ola Nilsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Madis Suurkula
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Svante Jansson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Skånberg, J., Ahlman, H., Benjegård, SA. et al. Indium-111-octreotide Scintigraphy, Intraoperative Gamma-detector Localisation and Somatostatin Receptor Expression in Primary Human Breast Cancer. Breast Cancer Res Treat 74, 101–111 (2002). https://doi.org/10.1023/A:1016120529858

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016120529858

Search

Navigation